UK tissue regulator's fees "will deter small companies"
This article was originally published in Scrip
Executive Summary
Organisations representing UK companies in the life sciences sector say that the Human Tissue Authority's new fees are "unrealistically excessive" and that the 2009-10 fee schedule is being implemented after a consultation process that was "conducted with a lack of rigour".